Huma acquires Aluna & partners with Eckuity to boost growth
Huma has announced the acquisition of Aluna and a partnership with investment firm Eckuity Capital to expand its digital healthcare offerings and accelerate its mergers and acquisitions (M&A) strategy.
The acquisition of Aluna, a United States-based company specialising in intelligent remote monitoring and management of respiratory diseases, will see its respiratory solutions relaunched on the Huma Cloud Platform and expand Huma's capabilities in chronic respiratory care.
Huma's collaboration with Eckuity Capital is intended to support an expanded M&A drive, aimed at building comprehensive solutions to serve health systems, pharmaceutical companies, contract research organisations, and patients globally.
The partnership will provide resources to help Huma acquire and integrate complementary businesses into its digital health ecosystem.
Youssef Sebban, Managing Partner at Eckuity Capital, said: "We help Huma acquire companies that, on their own, may not fully realise their potential—but when integrated into Huma's cloud platform, become highly complementary and transformative."
"This synergy not only amplifies their impact on the healthcare ecosystem but also drives outsized value creation for investors and shareholders."
Dan Vahdat, Founder and Chief Executive Officer of Huma, stated: "Today's announcements mark a new chapter for Huma as we strive to build the most impactful healthcare company in the world."
"By integrating Aluna's leading respiratory monitoring solutions into our platform and working to secure growth capital for further acquisitions, we are creating a complete ecosystem to deliver even greater value to health systems, life sciences, and—most importantly—patients around the world."
Huma's cloud platform currently supports more than 4,500 hospitals and clinics and is used by over 50 million individuals in more than 70 countries. The platform holds regulatory certifications, including FDA 510(k) Class II in the United States and EU MDR Class IIb status in Europe, and is implemented in national healthcare initiatives in several countries such as the US, UK, Germany, Greece, and Saudi Arabia.
The acquisition of Aluna will add over 150 US-based health systems and clinic networks to Huma's network, enhancing its reach in the respiratory health sector. Aluna, headquartered in San Francisco, is known for its remote patient monitoring platform as well as its proprietary peak flow meters for respiratory care.
With the integration, Aluna's solutions will be upgraded and relaunched on the Huma Cloud Platform, including an elevation of product classification to FDA Class II. Existing Aluna customers will now have access to Huma's disease management programmes, of which approximately 500,000 patients with conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnoea are currently served.
Charvi Shetty, Chief Executive Officer of Aluna, said: "Joining forces with Huma offers a remarkable opportunity to amplify our impact and extend the reach of our AI-driven respiratory management platform to a wider patient base worldwide."
"We are excited about the prospect of integrating our technology into the Huma Cloud Platform, creating a truly holistic digital health solution that empowers both patients and healthcare professionals in the effective management of respiratory conditions."
Vishal Jain, Managing Partner at Eckuity Capital, commented: "We believe Dan and Huma's leadership team brings the much-needed bold vision to develop one of the most meaningful healthcare companies of the 21st century."
"The AI-led transformation of care that we will witness over the next two decades needs a reliable, real-time, and responsive infrastructure that very few companies can offer globally, and Huma is one of the most capable companies that can deliver on this promise."
Goodwin Proctor acted as exclusive legal advisor to Huma on the Aluna transaction, with Peak Technology Partners serving as exclusive financial advisor to Aluna.
